Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America

Table 3

Distribution of abnormal liver enzymes at admission and at 1 week of hospitalization.

Liver enzyme	Patients with ALEx2 at admission (n = 87)	Patients with de novo-ALEx2 (n = 84)
AST > 2UNL, n (%)	59 (67.8)	67 (79.8)
ALT >2 UNL, n (%)	46 (52.9)	45 (53.6)
TBil >2 UNL, n (%)	6 (6.9)	8 (9.5)
ALP >2 UNL, n (%)	8 (9.2)	11 (13.1)
GGT >2 UNL, n (%)	32 (36.2)	13 (15.5)

ALEx2, abnormal liver enzymes >2 times over the upper limit of normal; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TBil, total bilirubin; GGT, gamma-glutamyl transferase; ALP, alkaline phosphatase.